STIM1 and breast cancer: A microarray study of breast tumor revealed that the high STIM1/STIM2 expression profiles accompanied by augmented SOCE were correlated with the breast cancer subtype with the poorest prognosis, suggesting the clinical significance of STIM1/STIM2 ratio in breast cancer [45].